The body's thermostat for calcium might be set too high

Familial Hypocalciuric Hypercalcemia + other calcium sensing disorders - pathophysiology, treatment · 13:59 · Video: Armando Hasudungan · Watch at the source

In short: Your body relies on specific sensors to regulate blood calcium levels. In certain families, genetic mutations miscalibrate these receptors, causing the system to accept higher concentrations than normal. This condition often remains hidden because it is typically asymptomatic, yet identifying it correctly prevents unnecessary surgeries and informs family health.

Familial hypocalciuric hypercalcemia (FHH) is a genetic condition where the body's internal thermostat for calcium is miscalibrated. Most commonly caused by variants in the CASR gene, it results in lifelong elevated serum calcium levels despite relatively low amounts of calcium being excreted in the urine—a state known as hypocalciuria. Because FHH typically follows a benign course and patients are often asymptomatic, it can be easily overlooked or mistaken for more severe conditions.

The underlying mechanism involves three primary genetic pathways that impair how the body senses calcium. The most frequent cause is an inactivating mutation in the calcium-sensing receptor (CASR), which encodes a G-protein coupled receptor. Other mechanisms include mutations in the GNA11 gene, which produces an accessory G-protein required for CASR signaling, or the AP2S1 gene, which involves an adaptor protein for receptor endocytosis. These defects lead to an impaired sensing function, effectively raising the "set point" at which the body recognizes calcium levels as sufficient.

Distinguishing FHH from primary hyperparathyroidism (PHPT) is critical because their treatments are fundamentally different. While PHPT often requires surgical intervention (parathyroidectomy), individuals with FHH do not benefit from surgery. Clinicians use a urinary calcium clearance to creatinine clearance ratio (UCCCR) to differentiate the two; a ratio of less than 0.02 typically indicates FHH in vitamin D-replete individuals. Identifying FHH is vital not just for the patient, but for their entire family, as the condition follows an autosomal dominant inheritance pattern with high penetrance.

While most cases are mild, some affected individuals may rarely develop complications like pancreatitis or chondrocalcinosis. In symptomatic cases of FHH, medications like the calcimimetic cinacalcet may be used to manage hypercalcemia. Because serum calcium is now a routine part of basic metabolic panels, many patients are diagnosed incidentally without showing any classic symptoms.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-familial-hypocalciuric-hypercalcemia-other-calcium-sensing-d.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…